nepafenac has been researched along with Innate Inflammatory Response in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 6 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Graff, G; Moran, HW; Nolan, JC; Sancilio, LF; Shamblee, DA; Walsh, DA; Welstead, WJ | 1 |
| Aggarwal, P; Bardoloi, N; Burgute, PS; Deb, AK; Dholkawala, R; Gokhale, T; Sarkar, S | 1 |
| Balogh, GT; Budai-Szűcs, M; Csorba, A; Facskó, R; Gyarmati, B; Katona, G; Nagy, ZZ; Szente, L; Vincze, A; Zelkó, R | 1 |
| Gupta, G; Gupta, PC; Gupta, R; Jinagal, J; Khurana, S; Ram, J; Sahu, S | 1 |
| Donnenfeld, ED; Holland, EJ; Solomon, KD | 2 |
| Brona, P; Grzybowski, A | 1 |
| Bucolo, C; Drago, F; Marrazzo, G; Platania, CB; Romano, GL; Salomone, S | 1 |
| Achiron, A; Burgansky, Z; Dzhanov, Y; Gershoni, A; Gur, Z; Karmona, L; Mimouni, M | 1 |
| Chen, Y; Wang, E; Xia, S; Zhao, X | 1 |
| Cavanagh, HD; Maxwell, WA; Meuse, PA; Reiser, HJ; Sager, DP; Stewart, RH; Walters, TR | 1 |
| Gow, JA; McNamara, TR; Song, CK | 1 |
| Cojocaru, I; Pop, A; Stefan, C | 1 |
| Hanemoto, T; Hayashi, K; Miyake, S; Miyata, K; Noge, S; Numaga, J; Saito, I; Yabe, N; Yata, K | 1 |
| Brady, MT; Dahlin, DC; Flanagan, JG; Gamache, DA; Kapin, MA; McDonough, TJ; Rawji, MH; Sanders, ME; Yanni, JM | 1 |
| Ball, SL; Bingaman, DP; Du, Y; Jamison, JA; Kern, TS; Kim, M; Miller, CM; Mohr, S; Zheng, L | 1 |
| Graff, G; Ke, TL; Spellman, JM; Yanni, JM | 1 |
2 review(s) available for nepafenac and Innate Inflammatory Response
| Article | Year |
|---|---|
Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials.
Topics: Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Humans; Inflammation; Ketorolac; Phenylacetates; Postoperative Complications; Randomized Controlled Trials as Topic; Visual Acuity | 2017 |
[Progresses in antiinflamatory treatment in cataract surgery].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Drug Therapy, Combination; Eye Diseases; Glucocorticoids; Humans; Inflammation; Macular Edema; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Phenylacetates; Postoperative Care; Treatment Outcome | 2011 |
5 trial(s) available for nepafenac and Innate Inflammatory Response
| Article | Year |
|---|---|
Comparison of once daily dose of 0.3% nepafenac alone and three times dose of 0.1% nepafenac alone in pain and inflammation control after phacoemulsification.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Double-Blind Method; Humans; Inflammation; Middle Aged; Ophthalmic Solutions; Pain; Phacoemulsification; Phenylacetates; Prospective Studies; Single-Blind Method | 2022 |
Quantification of Inflammation Following Nd:YAG Laser Capsulotomy and Assessing the Anti-inflammatory Effects of Nepafenac 0.1% and Betamethasone 0.1.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Betamethasone; Capsule Opacification; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glucocorticoids; Humans; Inflammation; Laser Therapy; Lasers, Solid-State; Male; Middle Aged; Phacoemulsification; Phenylacetates; Postoperative Complications; Prospective Studies; Tomography, Optical Coherence; Treatment Outcome; Visual Acuity; Young Adult | 2021 |
Safety and efficacy of nepafenac punctal plug delivery system in controlling postoperative ocular pain and inflammation after cataract surgery.
Topics: Adult; Benzeneacetamides; Cataract; Double-Blind Method; Eye Pain; Humans; Inflammation; Phenylacetates; Pilot Projects; Postoperative Complications; Prospective Studies; Punctal Plugs; Treatment Outcome | 2021 |
Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Double-Blind Method; Drug Administration Schedule; Eye Diseases; Female; Humans; Inflammation; Male; Middle Aged; Pain, Postoperative; Phenylacetates; Prospective Studies; Treatment Failure | 2008 |
[Phase III open-label study of nepafenac ophthalmic suspension 0.1% for inflammation and ocular pain following ophthalmic surgery].
Topics: Adult; Aged; Benzeneacetamides; Eye Diseases; Eye Pain; Female; Humans; Inflammation; Male; Middle Aged; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Pain, Postoperative; Phenylacetates; Treatment Outcome | 2012 |
11 other study(ies) available for nepafenac and Innate Inflammatory Response
| Article | Year |
|---|---|
Antiinflammatory agents. 4. Syntheses and biological evaluation of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid.
Topics: Acetamides; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Benzeneacetamides; Carrageenan; Chemical Phenomena; Chemistry; Cyclooxygenase Inhibitors; Female; Gastrointestinal Diseases; Indomethacin; Inflammation; Male; Molecular Structure; Phenylacetates; Prodrugs; Rats | 1990 |
Cyclodextrin-enabled nepafenac eye drops with improved absorption open a new therapeutic window.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclodextrins; Inflammation; Ophthalmic Solutions; Phenylacetates; Swine | 2023 |
Comment on: Safety and efficacy of a nepafenac punctal plug delivery system in controlling postoperative ocular pain and inflammation after cataract surgery.
Topics: Benzeneacetamides; Cataract; Eye Pain; Humans; Inflammation; Phenylacetates; Punctal Plugs | 2021 |
Reply to comment on: Safety and efficacy of a nepafenac punctal plug delivery system in controlling postoperative ocular pain and inflammation after cataract surgery.
Topics: Benzeneacetamides; Cataract; Eye Pain; Humans; Inflammation; Phenylacetates; Punctal Plugs | 2021 |
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophenones; Bromobenzenes; Cyclooxygenase 2; Dinoprostone; Indomethacin; Inflammation; Lipopolysaccharides; Male; Phenylacetates; Rats, Sprague-Dawley; Retina; Retinal Hemorrhage; Uveitis | 2014 |
Comparison of the Tolerability of Diclofenac and Nepafenac.
Topics: Administration, Topical; Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Diclofenac; Double-Blind Method; Female; Humans; Inflammation; Male; Molecular Structure; Ophthalmic Solutions; Pain Measurement; Pain, Postoperative; Phenylacetates; Prospective Studies; Visual Analog Scale | 2016 |
Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Clinical Trials as Topic; Drug Administration Schedule; Drug Approval; Humans; Inflammation; Pain, Postoperative; Phenylacetates; United States; United States Food and Drug Administration | 2009 |
Nepafenac: new drug. After cataract surgery: just another NSAID eye drop. No better than other NSAID eye drops, and less convenient to use.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Cataract Extraction; Double-Blind Method; Drug Approval; Europe; Humans; Inflammation; Ophthalmic Solutions; Pain, Postoperative; Phenylacetates; Randomized Controlled Trials as Topic | 2009 |
Inflammation-mediated retinal edema in the rabbit is inhibited by topical nepafenac.
Topics: Administration, Topical; Animals; Benzeneacetamides; Carbon Radioisotopes; Concanavalin A; Drug Evaluation, Preclinical; Inflammation; Papilledema; Pharmacokinetics; Phenylacetates; Rabbits; Software; Tissue Distribution; Tomography | 2003 |
Topical administration of nepafenac inhibits diabetes-induced retinal microvascular disease and underlying abnormalities of retinal metabolism and physiology.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Benzeneacetamides; Caspase 3; Caspase 6; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Dinoprostone; Evoked Potentials, Visual; Inflammation; Male; Matrix Metalloproteinase 2; Nitric Oxide; Ophthalmic Solutions; Phenylacetates; Random Allocation; Rats; Rats, Inbred Lew; Retina; Retinal Vessels; Streptozocin; Superoxides; Vascular Endothelial Growth Factors | 2007 |
Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: II. In vitro bioactivation and permeation of external ocular barriers.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Biotransformation; Cornea; Diclofenac; Eye; Eye Diseases; Humans; In Vitro Techniques; Inflammation; Permeability; Phenylacetates; Prodrugs; Rabbits; Tissue Distribution | 2000 |